Citations

Clear

4 citation(s) found for "Singh, Simardeep".

Beyond Weight Loss: Tolerability, Acceptability, and Patient-Centered Outcomes of GLP-1 Receptor Agonists in Polycystic Ovary Syndrome
Tauseef, Urvah , Farook, Farshi , Shetty, Vaishnavi J. , Ramos-Ocola, Edith , Premkumar, Chandra Rupini , Haider, Muhammad Zaryab , Gandhi, Aashna , Shingala, Tunisha , Singh, Simardeep , Tahir, Muhammad Moiz , Wilson, Sancia Mary Jerold, Saraboji, Kaaviyashri , Yadav, Jyoti , Bumrah, Simardeep Kaur, Bilgaiyan, Rashi , Elangovan, Poonguzhali , Arunachalam, Shivaram P.

Mayo Clinic

Reproductive Medicine | October 5, 2026 | Volume: 7 | Issue: 4 | Pages: 55

10.3390/reprodmed7040055 Get It

Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a promising therapeutic option for women with polycystic ovary syndrome (PCOS). Clinical trials and data demonstrate significant improvements in body weight, insulin resistance, hyperandrogenism, and, in some studies, menstrual regularity and reproductive outcomes. However, the current evidence base remains disproportionately focused on short-term metabolic and anthropometric endpoints, while outcomes most relevant to patients—including treatment satisfaction, gastrointestinal tolerability, psychological well-being, body image, fertility planning, financial burden, and long-term adherence—remain inadequately characterized. Methods: We searched PubMed and Google Scholar for English-language literature published between 2021 and 2026, using structured keyword searches. This narrative review evaluates the literature on GLP-1RA use in PCOS beyond weight-focused outcomes, examining mechanisms of action, comparative tolerability across agents, and patient-centered domains including quality of life, eating behavior, and reproductive planning. Results: The published literature reveals a substantial gap between trial-reported completion rates and treatment success, and actual persistence and patient satisfaction. This discrepancy is particularly consequential in PCOS, where treatment decisions intersect with high baseline rates of depression, anxiety, and body image disturbance, and where ovulatory benefits must be weighed against mandatory discontinuation before conception. Conclusions: We identify a systematic absence of validated patient-reported outcome measures, standardized core outcome sets, and long-term follow-up data after treatment withdrawal. This review proposes a research agenda prioritizing patient-centered endpoints as co-primary outcomes, structured assessment of acceptability and persistence, qualitative and mixed-methods approaches, and a dedicated study of fertility planning and treatment interruption.
Gastric Motility Disorders Post Organ Transplantation—A Comprehensive Review
Bharadwaj, Hareesha Rishab , Koo, Thai Hau , Dahiya, Dushyant Singh , Dalal, Priyal, Arab, Sammy , Chhatwal, Karanjot , Bhatti, Taha, Malik, Maham , Singh, Simardeep, Hasan, Fariha , Tofani, Christina , Infantolino, Anthony, Arab, Sammy , Chhatwal, Karanjot , Bhatti, Taha , Malik, Maham , Infantolino, Anthony , Dahiya, Dushyant Singh , Koo, Thai Hau , Bharadwaj, Hareesha Rishab , Fuad, Muhtasim

Mayo Clinic

Journal of Clinical Medicine | October 29, 2025 | Volume: 14 | Issue: 21 | Pages: 7581

10.3390/jcm14217581 | PMID 41226976 Get It

Motility disorders, particularly gastroparesis, are prevalent complications following solid organ transplantation, significantly impacting quality of life, nutritional status, graft survival, and mortality. This comprehensive review synthesises evidence from PubMed, Scopus, and Embase databases on pathophysiology, clinical manifestations, diagnosis, management, and prognostic factors across transplant types. Mechanisms include vagal nerve injury (highest in lung transplants, prevalence 40–91%), immunosuppressive effects (e.g., tacrolimus accelerates motility; mycophenolate impairs it), surgical trauma, microbiome dysbiosis (reduced Firmicutes/Bacteroidetes ratio), and metabolic factors like post-transplant diabetes (OR 5.17 in kidney recipients). Pediatric and thoracic recipients face the highest risks, with lung transplant gastroparesis conferring a 2.7-fold increased mortality/retransplantation hazard (p < 0.05). Diagnosis relies on gastric emptying scintigraphy (gold standard, sensitivity 85–95%) and wireless motility capsules (100% sensitivity for delay), while management encompasses prokinetics (60–80% response), endoscopic G-POEM (85% success), gastric electrical stimulation (100% quality-of-life improvement in series), and nutritional support. Prognostic factors include younger age (better intervention response), aetiology (anatomical worse than metabolic), and early therapy success. Outcomes vary: lung recipients experience severe impacts on chronic allograft dysfunction (83% oesophageal motility abnormalities correlate with 66–67% rejection). Future directions emphasise microbiome therapies, AI predictive models (AUC 0.85), and wearables for continuous monitoring. Multidisciplinary approaches are essential to balance immunosuppression with GI management, addressing ethical dilemmas like drug interactions and access disparities. Ultimately, early screening and personalised interventions can mitigate complications, enhancing long-term transplant success.
CMV Viremia and Colitis in Simultaneous Pancreas-Kidney Transplantation
Singh, Simardeep, Karatela, Shifa , Patel, Mipasha, Amin, Juhi , Gandhi, Devisha, Oring, Justin , Rajani, Aayushi J , Karatela, Shifa , Patel, Mipasha , Amin, Juhi V , Oring, Justin , Rajani, Aayushi J. , Patel, Mipasha, Gandhi, Devisha

Mayo Clinic

American Journal of Case Reports | April 14, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.946818 | PMID 40375543 Get It

S1273 Seasonal Variation in Hospital Admissions, Length of Stay and Mortality for Patients With Inflammatory Bowel Disease
Vasireddy, Ramya , Mensah, Boniface , Singh, Simardeep, Gaddipati, Greeshma, Akhiwu, Ted , Egbo, Olachi, Barrow, Jasmine, Atarere, Joseph Okiemute , Delungahawatta, Thilini , Bilalaga, Mariah Malak , Dunleavy, Katie A.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S907-S907

10.14309/01.ajg.0001034460.96830.7c Get It